1.Effect of knockout ST2 expression on intestinal microflora in mice with ConA-induced autoimmune hepatitis
Renquan JIANG ; Jifeng TANG ; Yujue HE ; Jinfang XIA ; Jinpiao LIN ; Qishui OU
Chinese Journal of Immunology 2025;41(3):529-534
Objective:To investigate the effect of growth stimulation expressed gene 2(ST2)on intestinal microflora of mice with ConA-induced autoimmune hepatitis(AIH)by knockout.Methods:ST2 gene knockout mice were constructed by gene knockout technique.On this basis,AIH mouse model was established by ConA induction.The relative expression of cytokines was detected by real-time fluorescence quantitative PCR(RT-PCR).Intestinal microorganisms were sequenced using the 16S rRNA high-through put sequencing method,and the sequencing results were analyzed using Microbial Ecology related software and database.Results:Com-pared with the control group,ALT and AST were decreased,the damage of liver was mild,and the relative expression of IL-6 was also decreased in the liver of mice with ConA-induced AIH after ST2 gene knockout.There was no significant difference in the ACE and CHAO indices of the abundance of reactive flora.There was no significant difference between Shannon index and Simpson index re-flecting bacterial diversity.Psychrobacter,unclassified_Clostridia,Halothiobacillus,Clostridium_XlVa and Haemophilus genus content increased;Romboutsia,Rikenella,Parabacteroides and unclassified_Clostridiales bacterial content reduce.The areas under the receiv-er operator characteristic(ROC)curves were 0.88,0.89,0.88,0.80,0.90,0.90,0.84,0.91 and 0.84,respectively.Conclusion:Knockout of ST2 gene expression in mice with AIH can reduce liver injury and inflammation,and does not affect the distribution abun-dance and diversity of intestinal flora.However,there are differences among bacteria genera,and it has good diagnostic value.
2.Essential tremor plus affects disease prognosis: A longitudinal study.
Runcheng HE ; Mingqiang LI ; Xun ZHOU ; Lanqing LIU ; Zhenhua LIU ; Qian XU ; Jifeng GUO ; Xinxiang YAN ; Chunyu WANG ; Hainan ZHANG ; Irene X Y WU ; Beisha TANG ; Sheng ZENG ; Qiying SUN
Chinese Medical Journal 2025;138(1):117-119
3.Effect of knockout ST2 expression on intestinal microflora in mice with ConA-induced autoimmune hepatitis
Renquan JIANG ; Jifeng TANG ; Yujue HE ; Jinfang XIA ; Jinpiao LIN ; Qishui OU
Chinese Journal of Immunology 2025;41(3):529-534
Objective:To investigate the effect of growth stimulation expressed gene 2(ST2)on intestinal microflora of mice with ConA-induced autoimmune hepatitis(AIH)by knockout.Methods:ST2 gene knockout mice were constructed by gene knockout technique.On this basis,AIH mouse model was established by ConA induction.The relative expression of cytokines was detected by real-time fluorescence quantitative PCR(RT-PCR).Intestinal microorganisms were sequenced using the 16S rRNA high-through put sequencing method,and the sequencing results were analyzed using Microbial Ecology related software and database.Results:Com-pared with the control group,ALT and AST were decreased,the damage of liver was mild,and the relative expression of IL-6 was also decreased in the liver of mice with ConA-induced AIH after ST2 gene knockout.There was no significant difference in the ACE and CHAO indices of the abundance of reactive flora.There was no significant difference between Shannon index and Simpson index re-flecting bacterial diversity.Psychrobacter,unclassified_Clostridia,Halothiobacillus,Clostridium_XlVa and Haemophilus genus content increased;Romboutsia,Rikenella,Parabacteroides and unclassified_Clostridiales bacterial content reduce.The areas under the receiv-er operator characteristic(ROC)curves were 0.88,0.89,0.88,0.80,0.90,0.90,0.84,0.91 and 0.84,respectively.Conclusion:Knockout of ST2 gene expression in mice with AIH can reduce liver injury and inflammation,and does not affect the distribution abun-dance and diversity of intestinal flora.However,there are differences among bacteria genera,and it has good diagnostic value.
4.Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson’s disease
Yuwen ZHAO ; Lixia QIN ; Hongxu PAN ; Tingwei SONG ; Yige WANG ; Xiaoxia ZHOU ; Yaqin XIANG ; Jinchen LI ; Zhenhua LIU ; Qiying SUN ; Jifeng GUO ; Xinxiang YAN ; Beisha TANG ; Qian XU
Chinese Medical Journal 2024;137(4):450-456
Background::Genetic variants of dopaminergic transcription factor-encoding genes are suggested to be Parkinson’s disease (PD) risk factors; however, no comprehensive analyses of these genes in patients with PD have been undertaken. Therefore, we aimed to genetically analyze 16 dopaminergic transcription factor genes in Chinese patients with PD.Methods::Whole-exome sequencing (WES) was performed using a Chinese cohort comprising 1917 unrelated patients with familial or sporadic early-onset PD and 1652 controls. Additionally, whole-genome sequencing (WGS) was performed using another Chinese cohort comprising 1962 unrelated patients with sporadic late-onset PD and 1279 controls.Results::We detected 308 rare and 208 rare protein-altering variants in the WES and WGS cohorts, respectively. Gene-based association analyses of rare variants suggested that MSX1 is enriched in sporadic late-onset PD. However, the significance did not pass the Bonferroni correction. Meanwhile, 72 and 1730 common variants were found in the WES and WGS cohorts, respectively. Unfortunately, single-variant logistic association analyses did not identify significant associations between common variants and PD. Conclusions::Variants of 16 typical dopaminergic transcription factors might not be major genetic risk factors for PD in Chinese patients. However, we highlight the complexity of PD and the need for extensive research elucidating its etiology.
5.Advances in the TAF1 gene
Qian ZENG ; Beisha TANG ; Jifeng GUO
Chinese Journal of Neurology 2021;54(9):967-972
TAF1 gene encodes TATA-box binding protein-associated factor-1, which serves as a scaffold for the assembly of the transcription factor ⅡD and participates in the transcription of many genes in eukaryotic cells. Human TAF1 possesses intrinsic protein kinase activity, histone acetyltransferase activity as well as ubiquitin-activating and conjugating activity, and these activities have been mapped to different domains. Currently, TAF1 has been identified as the causative gene of X-linked dystonia-parkinsonism and X-linked mental retardation. What′s more, a series of functional analysis have demonstrated the importance of TAF1 gene in cell cycle and cell growth, and its relationship with neurodevelopment and tumorigenesis has also been reported. This review summarizes the research progress of TAF1 including structure, phenotypes and biological function.
6.Compassionate use of polatuzumab vedotin in patients with relapsed/refractory diffuse large B-cell lymphoma: report of one case and review of literature
Jianqiu WU ; Weiyan TANG ; Yue TENG ; Xueting FAN ; Jifeng FENG
Journal of Leukemia & Lymphoma 2021;30(7):411-414
Objective:To investigate the efficacy and safety of polatuzumab vedotin (pola) in treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).Methods:The clinical data of 1 DLBCL patient receiving multiple treatments in Jiangsu Cancer Hospital in May 2016 were retrospectively analyzed, and the related literature was reviewed.Results:The patient, a 57-year-old male, was diagnosed with DLBCL in May 2016. Since June 2016, he had received treatments with four lines including anti-CD20 monoclonal antibody combined with chemotherapy, chemotherapy only and chimeric antigen receptor T cell (CAR-T). However, the disease relapsed or progressed after all treatments. Therefore, the patient had received 6 cycles of pola combined with rituximab since December 2019. Unexpected adverse events were not found during the treatment. The evaluation of clinical efficacy was complete remission after the end of treatment. The progression-free survival time was more than 13 months with follow-up until January 2021.Conclusion:Pola initially shows good efficacy and safety in treatment of patients with relapsed/refractory DLBCL.
7.Recent advance in Parkinson's disease with excessive daytime sleepiness
Yaqin XIANG ; Beisha TANG ; Jifeng GUO
Chinese Journal of Neuromedicine 2021;20(11):1172-1176
Excessive daytime sleepiness (EDS) is a common sleep disturbance in Parkinson's disease (PD), and the prevalence of EDS in PD patients is obviously higher than that in the normal population. EDS not only seriously influences the quality of life of PD patients but also increases the risk of accidents while driving and the risk of falling, therefore, timely recognition and intervention of EDS are of great importance. In order to deepen the understanding of EDS, this review will summarize the recent advance in epidemiology, etiology and pathogenesis, clinical significance, neuroimaging, clinical assessment, and clinical management of EDS.
8.Mechanism of re-emergent tremor in Parkinson′s disease
Taole LI ; Beisha TANG ; Jifeng GUO
Chinese Journal of Neurology 2020;53(7):544-547
Parkinson′s disease is a common degenerative disease of the central nerve system, mainly caused by the degeneration of dopaminergic neurons in the compact part of substantia nigra. Tremor is one of the most common symptoms of Parkinson′s disease. Part of patients changing posture position could cause the tremor suspended for a period of time, after that, the tremor appear again. This clinical phenomenon is characterized by the reproducibility of Parkinson′s disease tremor, called re-emergent tremor (RET). The cause of RET mechanism is still unclear and the relative researches are less. This review summarizes the possible mechanism, clinical features and significance of RET in Parkinson′s disease.
9.Advances in research on myoclonus-dystonia syndrome
Yanghong LI ; Beisha TANG ; Jifeng GUO
Chinese Journal of Neurology 2020;53(7):552-558
Myoclonus-dystonia syndrome (MDS) is a special type of dystonia-plus syndromes. It is an autosomal-dominant movement disorder syndrome characterized by myoclonus and dystonia and accompanied by certain mental symptoms. The disorder usually occurs in childhood. Myoclonus and dystonia are usually involved in upper limbs, trunk and neck. The main pathogenic gene of MDS is ε-sarcoglycan gene (SGCE). Up to date, the mechanism that how this gene leads to the disease is not clear. The continuous progress of MDS can cause disability and bring great pain to patients and their families. In recent years, significant progress has been made in the research of this disease. This article will systematically review the pathogenesis, clinical phenotype, genetics, diagnostic criteria, differential diagnosis and treatment of MDS.
10. Specifications for diagnosis and treatment of non-neonatal tetanus
Chuanlin WANG ; Si LIU ; Qingjun CHEN ; Zhujun SHAO ; Jifeng WU ; Zhao FAN ; Peige WANG ; Zhenggang ZHU ; Pin LAN ; Jianguo LI ; Yishan ZHENG ; Wubing HE ; Zhe XU ; Weidong TANG ; Jinman PANG ; Zhihong BAN ; Shuqing YANG ; Wentao DING ; Xifu ZHENG ; Qilong ZHANG
Chinese Journal of Trauma 2020;36(1):18-23
Tetanus consists of neonatal tetanus and non-neonatal tetanus. Non-neonatal tetanus remains a serious public health problem, although neonatal tetanus has been eliminated in China since 2012. Non-neonatal tetanus is a potential fatal disease. In the absence of medical intervention, the mortality rate of severe cases is almost 100%. Even with vigorous treatment, the mortality rate remains 30%-50% globally. These specifications aim to regulate non-neonatal tetanus diagnosis and treatment in China, in order to improve medical quality and safety. These specifications introduce the etiology, epidemiology, pathogenesis, clinical manifestations and laboratory tests, diagnosis, differential diagnosis, grading and treatment of non-neonatal tetanus.

Result Analysis
Print
Save
E-mail